Comparing the current results to its competitors, Biotricity Inc reported Revenue increase in the 3 quarter 2025 by 10.19 % year on year. The sales growth was above Biotricity Inc 's competitors' average revenue growth of 9.1 %, achieved in the same quarter.
Biotricity Inc , slower than the average decrease reported by the company's competitors of -11.4 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -11.4 %
Biotricity Inc 's Comment on Competition and Industry Peers
The cardiac event monitoring (COM) market features a limited number of competitors due to high entry barriers, including requirements for hardware devices, complex algorithms, ECG software, and access to monitoring centers. Among the five COM players, two have developed their own monitoring infrastructure and ECG software while utilizing TZ Medical's COM device, which is capital intensive and costly for most hospitals and clinics. Event Loop and Holter have maintained a significant share of the US event monitoring market despite increased competition. Biocore offers a one-piece solution with 3-channel ECGs and integrated cellular connectivity, distinguishing it from competitors who provide two-piece, 2-channel ECG solutions. Biocore's technology is designed for the Holter and Extended Holter market and is used in various healthcare settings. The company also targets chronic care management and remote patient monitoring markets, focusing on cardiologist offices, cardiology-specialized hospitals, and independent diagnostic testing facilities (IDTFs).
Company's competitiveness improved within Overall company, with revenue growth of 10.19 % and its market share increased to approx. 0.04 %. << More on BTCY Market Share.
*Market share is calculated based on total revenue.
Irhythm Technologies Inc is a healthcare company that focuses on providing remote cardiac monitoring solutions. Their business model revolves around offering wearable devices that continuously monitor heart rhythms, combined with cloud-based data analysis. They generate revenue by selling and leasing their devices, as well as providing analysis services and data reports to healthcare professionals.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Sources:
Biotricity Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Biotricity Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
